Target-controlled Intra veinous anesthesia during laparoscopic surgery

##plugins.themes.academic_pro.article.sidebar##

Published Jan 12, 2011
Download
pdf
Vol. 89 No. 1 (2011): Issue Jan 2011

##plugins.themes.academic_pro.article.main##

H. Jaoua
S Zghidi
A. Askri
A Jendoubi
N Ammar
S Lassili
W Laaribi
S. Darmoul
S. Khelifi
K. Ben Fadhel

Abstract

Background : The TCI is a mode of administration that provides greater security by allowing more accurate titration of the anesthetic agent. It leads to a better adaptation to the desired effects, and provide a great interest for the realization of anesthetic induction and the prediction of waking for a well- determined population.
Objective: The aim of our prospective study was to evaluate the feasibility of TCI in patients with morbid obesity undergoing laparoscopic surgery for obesity.
Methods: Thirty patients were included in this study. Age and BMI means were 32 years and 49.31 kg / m2. Our protocol was proposed to associate an hypnotic agent (propofol) to an opioid one (remifentanil) using the technique of the TCI, with respectively Schnider and Minto models.
Results: The induction protocol has brought good conditions for laryngoscopy with no hypertensive peak or desaturation episode. The period of unconsciousness was 89 seconds with an average target concentration of propofol of 5.1 mg / ml.
We also noted hemodynamic stability in 79% of patients at induction.
During both preparation phase and final installation of the patients, a low ERC to 2 hg / ml was consistent with a suitable hemodynami profile. We obtained hemodynamic stability by adapting target concentration of remifentanil at different operating times (Surgical incision: 3.64 hg / ml, insufflation of the peritoneum: 5.37 hg / ml, jejuno-jejunal resection anastomosis: 9 hg / ml, gastric resection and gastrojejunal anastomosis: 14.2 hg / ml). During this period, no episodes of bradycardia or hypotension were noticed.
During the recovery phase and while doing the distribution of CEP and CER according to the BMI of patients, we identified two groups: Group 1 (BMI <49 kg / m2): fast time extubation (11 min) and target concentrations of propofol and remifentanil respectively at 1.3 mg / ml and 1.25 hg / ml which is similar to most publications on this subject and Group 2 (BMI> 49 kg / m2): time-delayed extubation (23 min) with very low values of CEP and CER inconsistent with the literature data.

Keywords:

AIVOC, obesity, Propofol, Remifentanil

##plugins.themes.academic_pro.article.details##

References

  1. Viviand X, Léone M, Stolberg E. Induction and maintenance of intravenous anaesthesia using target-controlled infusion systems. Anaesthesiology 2001; 15:19-33.
  2. Glass PS, Shafer SL, Reves JG. Intravenous drug delivery systems. Anesthesia . new york: Churchil Livingstone; 2000: 377-411.
  3. applied to our daily anesthesia practice. Can J Anaesth 1999; 46: R122-30.
  4. Schnider TW, Minto CF, Shafer SL. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90: 1502-16.
  5. Servin FS, Bougeois B, Gomeni R. Pharmacokinetics of Propofol Administrated by Target-controlled Infusion to Alcoholic Patients. Anesthesiology 2003; 99: 576-85.
  6. Marik P, Varon J. The obese patient in the ICU. Chest 1998; 113: 492-8.
  7. Abernethy DR, Greenblatt DJ. Drug disposition in obese humans: an update. Clin Pharmacokinet 1986; 11: 199-213.
  8. Servin F, Farinotti R, Haberer JP. Propofol infusion for the maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. Anesthesiology 1993; 78: 657-65.
  9. Glass PSA, Hardman D, Kamiyama Y. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg 1993; 77: 1031- 40.
  10. Schnider TW, Minto CF, Gambus PL. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88: 1170-82.
  11. Marsh B, White M, Morton N. Pharmacokinetic model driven infusion of propofol in children. B J Anaesth 1991; 67: 41-8.
  12. Langeron O, Masso E, Huraux C. Prediction of difficult mask ventilation. Anesthesiology 2000; 92: 1229-36.
  13. Struys MM, De Smet T, Depoorter B. Comparison of plasma compartment versus two methods for effect compartment-- controlled target-controlled infusion for propofol. Anesthesiology 2000; 92:399-406.
  14. Arndt G A, Reiss W G, Bathke K A. Computer assisted continuous infusion for the delivery of target controlled infusions of propofol during outpatient surgery. Pharmacotherapy 1995; 15: 512-6.
  15. Minto CF, Schnider TW, Egan TD. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 1997; 86: 10-23.
  16. Rose JB, Theroux MC, Katz MS. The potency of succinylcholine in obese adolescents. Anesth Anelg 2000 ; 90 :576-8.
  17. Vuyk J, Mertens MJ, Olofsen E. Propofol anesthesia and rational opioid selection. Anesthesiology 1997; 87: 1549-62.
  18. De Castro V, Godet G, Mencia G. Target-Controlled Infusion for Remifentanil in Vascular Patients Improves Hemodynamics and Decreases Remifentanil Requirement. Anesth Analg 2003; 96: 33-8.
  19. De Baerdemaeker L, Jacobs S, Pattyn P. Influence of intraoperative opioid on postoperative pain and pulmonary function after laparoscopic gastric banding: remifentanil TCI vs sufentanil TCI in morbid obesity. British Journal of Anaesthesia 2007; 2: 1-8.
  20. Slepchenko G, Simon N, Goubaux B. Performance of Targetcontrolled Sufentanil Infusion in Obese Patients. Anesthesiology 2003; 98:65-73.
  21. Vuyk J.Pharmacokinetic and pharmacodynamic interactions between opioids and propofol.J Clin Anesth 1997; 9: 23-6.
  22. Servin FS, Marchand-Maillet F, DesmontsJM. Influence of analgesic supplementation on the target propofol concentrations for anaesthesia with ‘Diprifusor' TCI. Anesthesia 1998; 53 Suppl 1:72-6.
  23. Egan TD. Remifentanil pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 1995; 29: 80-94.